Loading insider details...
Latest Form 4 (Mar 12, 2026): Purchase of 15,000 LCTX shares, $24.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 12, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 15,000 | $24.4K |
| Mar 7, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 3,250,000 | n/a |
| Feb 14, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 31,250 | n/a |
| Dec 20, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 8,925 | n/a |
| Mar 12, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 2,300,000 | n/a |
| Feb 12, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 31,249 | n/a |
| Nov 22, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 40,000 | $24.0K |
| May 28, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 10,000 | $10.5K |
| Mar 8, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 1,900,000 | n/a |
| Feb 13, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 31,249 | n/a |